retatrutide type 2 diabetes trial results 2024 phase 2 Retatrutide Availability & Timeline Phase 2 trial results demonstrate – Retatrutide Results: 28.3% Weight Loss

Weight loss drugs have been available since the 1930s, but their popularity surged recently after the Food and Drug Administration (FDA) approved three GLP-1 receptor agonists for weight loss: Wegovy (semaglutide), Saxenda (liraglutide), and Ozempic (tirzepatide)

GLP-1s are FDA-approved and clinically proven medications

Sheds Geographic Availability Available in all 50 states Clinical Oversight and Safety at Shed All GLP-1 prescriptions handled by licensed medical providers Follow-up lab work only needed if you have certain existing health conditions Medications come from regulated 503A and 503B US pharmacies Clinical team available to contact via secure message

Some take longer, up to 30 minutes in rare cases

NO agitar - rotar suavemente

Insurance isnt accepted for the compounded medications